Methods
=======

Twenty-one inpatients (15 males/6 females) with an aver-age age of 23.7 years, who had been diagnosed with FEP according to *DSM-IV-TR (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision)* criteria, were evaluated using the Positive and Negative Syndrome Scale (PANSS). SPECT was acquired after injection of ^99m^Tc-HMPAO (^99m^Tc-hexamethylpropyleneamine oxime), before drug treatment and again after 3 months of treatment with either risperidone (mean dose 4.8 mg/day in 7 patients with predominantly negative symptoms), olanzapine (mean dose 11.6 mg/day in 9 patients with predominantly positive symptoms), and quetiapine (mean dose 440 mg/day in 5 patients with predominantly positive symptoms).

Exclusion criteria included the presence of a neurological or other somatic disorder that could modify rCBF, and previous exposure to antipsychotic drug treatment.

Results
=======

Baseline SPECT assessments revealed a diffuse low perfusion in the left parietal and temporal cortices, and in the right ventromedial frontal cortex, in 11 out of 14 patients with predominantly positive symptoms *([Figure 1](#DialoguesClinNeurosci-7-50-g001){ref-type="fig"} and [Figure 2](#DialoguesClinNeurosci-7-50-g002){ref-type="fig"}).* In 6 out of 7 patients with predominantly negative symptoms, we found a reduced perfusion in the frontal cortex (though bilateral, this reduction was more pronounced on the left side), decreased rCBF in the right basal ganglia, and low perfusion in the left orbitofrontal cortex *([Figure 3](#DialoguesClinNeurosci-7-50-g003){ref-type="fig"} ).* rCBF was normal in 4 patients (3 with predominantly positive symptoms and 1 with predominantly negative symptoms) .

![Baseline single photon emission computed tomography (SPECT) shows reduced perfusion in the left parietal and temporal cortices in 11 out of 14 patients with predominantly positive symptoms.](DialoguesClinNeurosci-7-50-g001){#DialoguesClinNeurosci-7-50-g001}

![Baseline single photon emission computed tomography (SPECT) shows reduced perfusion in the right ventromedial frontal cortex in 11 out of 14 patients with predominantly positive symptoms.](DialoguesClinNeurosci-7-50-g002){#DialoguesClinNeurosci-7-50-g002}

![Baseline single photon emission computed tomography (SPECT) shows reduced perfusion in the frontal cortex and the left orbitofrontal cortex and decreased regional cerebral blood flow (rCBF) in the right basal ganglia, in 6 out of 7 patients with predominantly negative symptoms.](DialoguesClinNeurosci-7-50-g003){#DialoguesClinNeurosci-7-50-g003}

The cortical abnormalities observed in patients at baseline persisted after treatment. After treatment, additional changes in subcortical structures were also observed, notably an increase in rCBF in the left caudate nuclei in 14 patients *([Figure 4](#DialoguesClinNeurosci-7-50-g004){ref-type="fig"})^[@ref3]^*

![Single photon emission computed tomography (SPECT) after treatment in 1 4 patients showed an increase in regional cerebral blood flow (rCBF) in the left caudate nuclei.](DialoguesClinNeurosci-7-50-g004){#DialoguesClinNeurosci-7-50-g004}

Discussion
==========

These results are consistent with the finding of Liddle et al on rCBF patterns in schizophrenia,^[@ref4],[@ref5]^ who reported both increases and decreases in rCBF, suggesting a dynamic imbalance rather than a fixed abnormality

Conclusion
==========

Our data suggest cortical abnormalities in rCBF, at baseline and after treatment, conceivably correlated with the type of symptoms. Subcortical changes appearing during treatment (notably in the left caudate nuclei) may be the consequence of treatment, but not of any one specific drug in particular.
